Two Sigma Investments, LP Immunome Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$11.54 - $22.11 $1.24 Million - $2.38 Million
107,846 New
107,846 $1.3 Million
Q3 2021

Nov 15, 2021
SELL
$12.5 - $27.76 $368,950 - $819,364
-29,516 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$16.33 - $32.33 $481,996 - $954,252
29,516 New
29,516 $511,000

Others Institutions Holding IMNM

# of Institutions
122
Shares Held
47.1M
Call Options Held
322K
Put Options Held
1.91M
View Full List

About Immunome Inc.

IMNM Quotes by TradingView
  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $134M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email